Rare diseases
Investigational molecules
Locations
Back to Germany1 675 clinical trials in Essen, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Mirikizumab for Children and Teens with Moderate to Severe Ulcerative Colitis
GermanyStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
GermanyStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
GermanyStudy Comparing SB27 and Pembrolizumab for Patients with Metastatic Non-Small Cell Lung Cancer
GermanyStudy on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure
GermanyStudy on the Effectiveness and Safety of Oral Minoxidil for Women with Androgenetic Alopecia
GermanyStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
GermanyStudy Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer
GermanyStudy on the Use of Florbetaben (18F) PET Imaging for Diagnosing Cardiac AL Amyloidosis in Patients
GermanyStudy of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
GermanyStudy on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments
GermanyStudy on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic colorectal cancer, breast cancer, and lymphoma treatments. Studies evaluate novel therapeutic combinations and targeted approaches for various cancer types.
Research includes evaluation of new drug combinations and immunotherapy approaches.
Studies examining preventive treatments for respiratory syncytial virus and related infections. Research focuses on vaccine development and immune response in different age groups.
Emphasis on protecting vulnerable populations including older adults and at-risk individuals.
Clinical research addressing Alzheimer's disease and acute cerebral ischemic stroke. Investigations into novel therapeutic approaches and diagnostic tools.
Focus on improving patient outcomes through innovative treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
